View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis.
Authors: Burmester G; Charité - Universitätsmedizin Berlin, Berlin, Germany., Trefler J; REUMA RESEARCH, Warsaw, Poland., Racewicz A; Zdrowie Osteo-Medic, Białystok, Poland., Jaworski J; Klinika Reuma Park, Warsaw, Poland., Zielińska A; MICS Centrum Medyczne, Warsaw, Poland., Krogulec M; NZOZ Lecznica Mak-Med, Nadarzyn, Poland., Jeka S; MICS Centrum Medyczne Toruń, CM UMK, Toruń, Poland., Wojciechowski R; Clinic and Department of Rheumatology and Systemic Diseases of Connective Tissue, University Hospital No. 2, Bydgoszcz, Poland., Kolossa K; MICS Centrum Medyczne, Bydgoszcz, Poland., Dudek A; Centrum Medyczne Amed, Warsaw, Poland., Krajewska-Włodarczyk M; Clinic of Rheumatology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland., Hrycaj P; Department of Rheumatology, Municipal Hospital, Kościan, Poland., Klimiuk PA; Department of Rheumatology and Internal Diseases, Medical University of Bialystok and Inter Clinic Piotr Adrian Klimiuk, Białystok, Poland., Kim S; Celltrion, Inc., Incheon, Republic of Korea., Suh J; Celltrion, Inc., Incheon, Republic of Korea., Yang G; Celltrion, Inc., Incheon, Republic of Korea., Kim Y; Celltrion, Inc., Incheon, Republic of Korea., Jung Y; Celltrion, Inc., Incheon, Republic of Korea., Park G; Celltrion, Inc., Incheon, Republic of Korea., Smolen JS; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. josef.smolen@meduniwien.ac.at.
Source: Clinical drug investigation [Clin Drug Investig] 2025 Aug; Vol. 45 (8), pp. 551-563. Date of Electronic Publication: 2025 Jul 12.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Comparative Study
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40650731
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burmester+G%22">Burmester G</searchLink>; Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Trefler+J%22">Trefler J</searchLink>; REUMA RESEARCH, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Racewicz+A%22">Racewicz A</searchLink>; Zdrowie Osteo-Medic, Białystok, Poland.<br /><searchLink fieldCode="AU" term="%22Jaworski+J%22">Jaworski J</searchLink>; Klinika Reuma Park, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Zielińska+A%22">Zielińska A</searchLink>; MICS Centrum Medyczne, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Krogulec+M%22">Krogulec M</searchLink>; NZOZ Lecznica Mak-Med, Nadarzyn, Poland.<br /><searchLink fieldCode="AU" term="%22Jeka+S%22">Jeka S</searchLink>; MICS Centrum Medyczne Toruń, CM UMK, Toruń, Poland.<br /><searchLink fieldCode="AU" term="%22Wojciechowski+R%22">Wojciechowski R</searchLink>; Clinic and Department of Rheumatology and Systemic Diseases of Connective Tissue, University Hospital No. 2, Bydgoszcz, Poland.<br /><searchLink fieldCode="AU" term="%22Kolossa+K%22">Kolossa K</searchLink>; MICS Centrum Medyczne, Bydgoszcz, Poland.<br /><searchLink fieldCode="AU" term="%22Dudek+A%22">Dudek A</searchLink>; Centrum Medyczne Amed, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Krajewska-Włodarczyk+M%22">Krajewska-Włodarczyk M</searchLink>; Clinic of Rheumatology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.<br /><searchLink fieldCode="AU" term="%22Hrycaj+P%22">Hrycaj P</searchLink>; Department of Rheumatology, Municipal Hospital, Kościan, Poland.<br /><searchLink fieldCode="AU" term="%22Klimiuk+PA%22">Klimiuk PA</searchLink>; Department of Rheumatology and Internal Diseases, Medical University of Bialystok and Inter Clinic Piotr Adrian Klimiuk, Białystok, Poland.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Suh+J%22">Suh J</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yang+G%22">Yang G</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jung+Y%22">Jung Y</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+G%22">Park G</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Smolen+JS%22">Smolen JS</searchLink>; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. josef.smolen@meduniwien.ac.at.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2025 Aug; Vol. 45 (8), pp. 551-563. <i>Date of Electronic Publication: </i>2025 Jul 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40650731
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40261-025-01453-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 551
    Titles:
      – TitleFull: Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burmester G
      – PersonEntity:
          Name:
            NameFull: Trefler J
      – PersonEntity:
          Name:
            NameFull: Racewicz A
      – PersonEntity:
          Name:
            NameFull: Jaworski J
      – PersonEntity:
          Name:
            NameFull: Zielińska A
      – PersonEntity:
          Name:
            NameFull: Krogulec M
      – PersonEntity:
          Name:
            NameFull: Jeka S
      – PersonEntity:
          Name:
            NameFull: Wojciechowski R
      – PersonEntity:
          Name:
            NameFull: Kolossa K
      – PersonEntity:
          Name:
            NameFull: Dudek A
      – PersonEntity:
          Name:
            NameFull: Krajewska-Włodarczyk M
      – PersonEntity:
          Name:
            NameFull: Hrycaj P
      – PersonEntity:
          Name:
            NameFull: Klimiuk PA
      – PersonEntity:
          Name:
            NameFull: Kim S
      – PersonEntity:
          Name:
            NameFull: Suh J
      – PersonEntity:
          Name:
            NameFull: Yang G
      – PersonEntity:
          Name:
            NameFull: Kim Y
      – PersonEntity:
          Name:
            NameFull: Jung Y
      – PersonEntity:
          Name:
            NameFull: Park G
      – PersonEntity:
          Name:
            NameFull: Smolen JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1918
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Clinical drug investigation
              Type: main
ResultId 1